Remy reviews how Nimodipine or Nimotop may be able to help with the pain, mitochondrial problems, immune system issues and cognitive problems in fibromyalgia and ME/CFS. She examines protocol, doses and cost as relates her experience with the drug.
Through his attorney David Nied of the Astralegal group, Dr. Montoya provided the following statement to Health Rising regarding the events of the past week. Health Rising covered them in this recent post. From David Nied: Following is a statement from my client, Dr....
Eleven years ago, Dr. Jose Montoya bucked his mentor’s advice to stay away from ME/CFS at all costs. In 2008, he made history by opening one of the first chronic fatigue syndrome (ME/CFS) clinic/research centers at a top university. While the promise of his...
The Spinal Series This is part three of a series examining spinal issues which may mimic chronic fatigue syndrome (ME/CFS) and fibromyalgia. The first two in the series involved two very ill ME/CFS patients who have recovered or are recovering following surgery to...
Dr. Peterson’s been using Ampligen in ME/CFS for 27 years. It seems like the drug has been sitting in limbo regarding ME/CFS forever – yet Ampligen is just one phase 3 trial away from becoming the first FDA-approved drug for ME/CFS – and no other...
Day two of the Conference – not all of which is covered here, started off with a physicians’ panel, then NIH Director Francis Collins showed up (covered later) just before the Intramural study presented some results, then it was onto Ian Lipkin, Dr. Oh,...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.